Autolus Therapeutics Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Autolus Therapeutics plc (AUTL) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Sep 2018
Operating Activities
Net Income-220.66-208.38-148.84-142.10-142.09-123.80-44.75
Depreciation & Amortization7.726.577.368.465.574.601.71
Deferred Income Tax-0.19-0.99-0.27-0.07-1.340.000.00
Stock Based Compensation15.4711.2012.019.9420.110.000.00
Change in Working Capital-23.661.260.540.411.411.454.73
Change in Inventory-4.230.000.000.000.000.000.00
Change in Accounts Payable1.59-0.510.02-1.821.440.000.00
Change in Other Working Capital12.510.800.514.83-0.030.000.00
Other Operating Activities12.5158.8016.044.83-2.8416.26-4.11
Net Cash from Operating Activities-206.27-145.59-112.31-117.86-117.76-101.48-31.54
Investing Activities
Capital Expenditures-34.8210.99-10.84-8.86-14.6818.67-9.12
Purchases of Investments-359.730.000.000.000.000.000.00
Other Investing Activities-12.740.000.000.000.000.000.00
Net Cash from Investing Activities-394.55-10.99-10.84-8.86-14.68-18.67-9.53
Financing Activities
Common Stock Issued549.98-0.91163.97245.9080.21108.86156.92
Other Financing Activities38.98-0.9159.6438.04-5.800.00-11.22
Net Cash from Financing Activities589.55-0.88223.61284.0674.42108.86156.92
Summary
Effect of Forex Changes on Cash-0.2615.03-28.38-0.750.685.16-5.83
Net Change in Cash-11.27-157.4672.09157.35-57.35-0.96115.85
Cash at Beginning of Period240.34382.76310.68154.09211.43217.56137.07
Cash at End of Period228.81240.34382.76310.68154.08211.47247.09
Free Cash Flow-241.09-156.57-123.15-126.72-132.44-120.15-41.07
Supplemental Disclosures
Interest Paid0.000.000.000.001.841.540.00
Income Taxes Paid2.39-0.550.470.36-19.780.000.00